CC · NYSE
Chemours (CC) Stock Price & Fundamentals
Chemours (CC) closed at $554.44 on Oct 9, 2026, down 0.83% from the previous close of $559.08.
Share price, past year
1Y −0.84%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $554.44 |
| Sep 30, 2026 | $558.83 |
| Aug 31, 2026 | $601.67 |
| Jul 31, 2026 | $605.30 |
| Jun 30, 2026 | $588.61 |
| May 29, 2026 | $618.85 |
| Apr 30, 2026 | $615.96 |
| Mar 31, 2026 | $600.29 |
| Feb 27, 2026 | $582.05 |
| Jan 30, 2026 | $546.85 |
| Dec 31, 2025 | $572.62 |
| Nov 28, 2025 | $588.18 |
| Oct 31, 2025 | $544.58 |
Key statistics
- Market cap
- $83.42B
- P/E (TTM)
- —
- EPS (TTM)
- −$2.00
- Revenue (TTM)
- $5.80B
- Net income (TTM)
- −$304.00M
- Shares outstanding
- 150.5M
- Dividend yield
- 0.06%
- 52-week range
- $541.90 – $633.13
Chemours's market cap is $83.42B, based on a share price of $554.44 and 150.5M shares outstanding as of Jun 30, 2026.
Financials
Chemours reported revenue of $5.81B for fiscal 2025, up 0.45% from fiscal 2024.
Chemours reported a net loss of $386.00M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $5.81B | +0.5% | −$386.00M | −6.7% | −$2.57 | $51.00M |
| FY2024ended Dec 31, 2024 | $5.78B | −4.9% | $69.00M | 1.2% | $0.46 | −$993.00M |
| FY2023ended Dec 31, 2023 | $6.08B | −11.0% | −$253.00M | −4.2% | −$1.70 | $186.00M |
| FY2022ended Dec 31, 2022 | $6.83B | +7.7% | $578.00M | 8.5% | $3.65 | $448.00M |
| FY2021ended Dec 31, 2021 | $6.35B | +27.7% | $608.00M | 9.6% | $3.60 | $537.00M |
| FY2020ended Dec 31, 2020 | $4.97B | −10.1% | $219.00M | 4.4% | $1.32 | $540.00M |
| FY2019ended Dec 31, 2019 | $5.53B | −16.8% | −$52.00M | −0.9% | −$0.32 | $169.00M |
| FY2018ended Dec 31, 2018 | $6.64B | +7.4% | $995.00M | 15.0% | $5.45 | $642.00M |
| FY2017ended Dec 31, 2017 | $6.18B | +14.5% | $746.00M | 12.1% | $3.91 | $229.00M |
| FY2016ended Dec 31, 2016 | $5.40B | — | $7.00M | 0.1% | $0.04 | $256.00M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $1.59B | −$274.00M | −$1.81 |
| Q1 FY2026ended Mar 31, 2026 | $1.38B | −$29.00M | −$0.19 |
| Q4 FY2025ended Dec 31, 2025 | $1.33B | −$47.00M | −$0.31 |
| Q3 FY2025ended Sep 30, 2025 | $1.50B | $46.00M | $0.31 |
| Q2 FY2025ended Jun 30, 2025 | $1.62B | −$380.00M | −$2.53 |
| Q1 FY2025ended Mar 31, 2025 | $1.37B | −$5.00M | −$0.03 |
| Q4 FY2024ended Dec 31, 2024 | $1.36B | −$11.00M | −$0.08 |
| Q3 FY2024ended Sep 30, 2024 | $1.51B | −$32.00M | −$0.22 |
Company profile
- Name
- Chemours Co
- Ticker
- CC
- Exchange
- NYSE
- Industry (SEC SIC)
- Chemicals & Allied Products
- Headquarters
- 1007 Market Street, Wilmington, DE 19801
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001627223
Recent SEC filings
- Sep 10, 2026
- Sep 9, 2026
- Aug 5, 2026
- Aug 4, 2026
- Jun 24, 2026
- May 5, 2026
- May 5, 2026
- Apr 30, 2026
Frequently asked questions
What is Chemours's stock price?
Chemours (CC) closed at $554.44 on Oct 9, 2026, down 0.83% from the previous close of $559.08.
What is Chemours's market cap?
Chemours's market cap is $83.42B, based on a share price of $554.44 and 150.5M shares outstanding as of Jun 30, 2026.
How much revenue does Chemours make?
Chemours reported revenue of $5.81B for fiscal 2025, up 0.45% from fiscal 2024.
Does Chemours pay a dividend?
Yes. Chemours declared $0.35 per share in dividends over the last four quarters, a yield of 0.06%.
Sources and methodology
Fundamentals come from Chemours Co's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures